A detailed history of D. E. Shaw & Co., Inc. transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 149,748 shares of RPTX stock, worth $202,159. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149,748
Holding current value
$202,159
% of portfolio
0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.75 - $3.99 $478 - $694
174 Added 0.12%
149,748 $515,000
Q2 2024

Aug 14, 2024

BUY
$3.02 - $4.7 $88,911 - $138,372
29,441 Added 24.51%
149,574 $493,000
Q1 2024

May 15, 2024

BUY
$4.53 - $8.41 $194,581 - $361,243
42,954 Added 55.66%
120,133 $565,000
Q4 2023

Feb 14, 2024

BUY
$3.22 - $11.79 $248,516 - $909,940
77,179 New
77,179 $563,000
Q2 2023

Aug 14, 2023

SELL
$8.63 - $12.53 $274,934 - $399,180
-31,858 Reduced 72.81%
11,895 $125,000
Q1 2023

May 15, 2023

SELL
$9.32 - $15.06 $592,015 - $956,626
-63,521 Reduced 59.21%
43,753 $430,000
Q4 2022

Feb 14, 2023

BUY
$12.5 - $18.13 $523,625 - $759,465
41,890 Added 64.07%
107,274 $1.58 Million
Q3 2022

Nov 14, 2022

SELL
$11.57 - $15.59 $102,475 - $138,080
-8,857 Reduced 11.93%
65,384 $793,000
Q2 2022

Aug 15, 2022

BUY
$8.45 - $14.84 $627,336 - $1.1 Million
74,241 New
74,241 $1.04 Million

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $56.6M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.